CytoDyn Inc.
CYDY
$0.3172
$0.00722.32%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.26M | 8.47M | 9.72M | 9.73M | 10.82M |
| Depreciation & Amortization | 0.00 | -11.00K | -9.00K | -5.00K | 0.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.32M | 16.89M | 16.30M | 15.99M | 18.06M |
| Operating Income | -15.32M | -16.89M | -16.30M | -15.99M | -18.06M |
| Income Before Tax | 3.75M | -7.09M | -14.25M | -19.04M | -49.84M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.75 | -7.09 | -14.25 | -19.04 | -49.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.75M | -7.09M | -14.25M | -19.04M | -49.84M |
| EBIT | -15.32M | -16.89M | -16.30M | -15.99M | -18.06M |
| EBITDA | -15.31M | -16.87M | -16.28M | -15.97M | -18.03M |
| EPS Basic | 0.00 | -0.01 | -0.02 | -0.02 | -0.05 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| EPS Diluted | 0.00 | -0.01 | -0.02 | -0.02 | -0.05 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 4.82B | 4.60B | 4.35B | 4.09B | 3.88B |
| Average Diluted Shares Outstanding | 4.89B | 4.66B | 4.42B | 4.15B | 3.88B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |